invivodata’s scientists defined the electronic patient reported outcomes (ePRO) industry over 25 years ago. Since that time, invivodata has evolved into the industry's only fully-integrated organization to deliver comprehensive Clinical Outcome Assessment (COA) solutions to biopharmaceutical companies who depend upon patient-centered research. invivodata delivers both strategic consulting services, via the PRO Consulting® division, as well as practical electronic Solutions that help customers strategically use all COAs, including patient-, clinician-, and observer-reported outcomes data (PRO, ClinRO, and ObsRO) to support labeling claims, enhance reimbursement strategies, and meet other clinical program objectives.
From crafting COA measurement strategy, to collecting COA data electronically with DiaryPRO, our electronic patient diary and SitePRO, our site-based device, invivodata’s consulting and eSolutions have been used in over 600 clinical programs, 67 countries, and 105 languages and dialects. invivodata's solutions have collected the primary endpoint data for pivotal studies that led to 16 regulatory approvals.
invivodata’s scientists defined the electronic patient reported outcomes (ePRO) industry over 25 years ago. Since that time, invivodata has evolved into the industry's only fully-integrated organization to deliver comprehensive Clinical Outcome Assessment (COA) solutions to biopharmaceutical companies who depend upon patient-centered research. invivodata delivers both strategic consulting services, via the PRO Consulting® division, as well as practical electronic Solutions that help customers strategically use all COAs, including patient-, clinician-, and observer-reported outcomes data (PRO, ClinRO, and ObsRO) to support labeling claims, enhance reimbursement strategies, and meet other clinical program objectives.
From crafting COA measurement strategy, to collecting COA data electronically with DiaryPRO, our electronic patient diary and SitePRO, our site-based device, invivodata’s consulting and eSolutions have been used in over 600 clinical programs, 67 countries, and 105 languages and dialects. invivodata's solutions have collected the primary endpoint data for pivotal studies that led to 16 regulatory approvals.
